SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
繁星洒满夜幕
Lv1
30 积分
2024-10-24 加入
最近求助
最近应助
互助留言
Structure, function and regulation of the Toll/IL‐1 receptor adaptor proteins
1小时前
已完结
Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy
4小时前
已完结
Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma
6天前
已完结
Initial Clinical Activity of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma
18天前
已关闭
Initial Clinical Activity of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed/Refractory B-Cell Lymphoma
18天前
已关闭
CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma
23天前
已完结
Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials
28天前
已完结
Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial
28天前
已完结
没有进行任何应助
感谢,速度真快
1小时前
感谢,点赞,速度真快
3小时前
感谢
6天前
感谢,点赞,速度真快
23天前
感谢,点赞,速度真快
28天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论